Time cohort study: patients with confirmed ovarian epithelial cancer at different time cutoff points before treatment, after surgery, during chemotherapy, and after chemotherapy, until clinically confirmed patients relapse. At least 50 patients are expected to be enrolled.
Age
20–70
Sex
FEMALE
Healthy volunteers
Accepted
You may be eligible if
Female
A diagnosed patient with epithelial ovarian cancer
Age ≤ 70
You may not be if
Male
Suffering from other malignant tumors
Non-compliant patient
Age above 70
Clareo Health | New Serum Biomarkers for Monitoring Early Diagnosis of Ovarian Cancer Recurrence
